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Dysfunction of suppressor cells has been implicated in the pathogenesis of immunode- 
ficiencies (1),  aplastic anemia (2),  recurrent fungal infections (3),  and autoimmunities 
such as systemic lupus erythematosus in humans (4),  and its equivalent in the NZB 
mouse (5). In addition, evidence is accumulating that suppressor cells of lymphoid and/ 
or macrophage origin may appear during the course of tumor growth both in rodents (6- 
8) and humans (9,  10). 
Suppressor T cells can be induced by soluble (11,  12) and cell associated antigens (11, 
13) and by .concanavalin A  (Con A) (14,  15). In some murine models it has been clearly 
demonstrated that the suppressor T-cell activity is genetically restricted in that the cell 
that is being suppressed, either directly or through suppressor factors, must share an I 
region component of the m~jor histocompatibility complex with the suppressor cell (12, 
13,  16). We  describe here  what  we  believe to  be  the  first example of a  genetically- 
restricted suppressor T-cell activity in man. 
Materials and Methods 
Venous blood mononuclear  cells were prepared from donors by defibrination  and centrifugation 
over a cushion of Ficoll Hypaque (F-H) followed by three washes before suspension in Eagle's 
minimal essential medium containing 10% heat-inactivated flesh normal male serum, 100 U of 
penicillin  and 100 ~g streptomycin/ml, 1% nonessential amino acids, and 2 mM fresh glutamine. 
Lymphocytes  to be used as stimulator cells in mixed leukocyte culture (MLC) were irradiated 
with a e°Co source to 2,250 rads. Triplicate samples of 125,000 responder cells were incubated in a 
final vol  of 0.2  ml with either 125,000 irradiated stimulator cells for  6 days or with a  1:800 
dilution of PHA-P  (Difco Laboratories,  Detroit,  Mich.)  or concanavalin A  (10  ~g/ml, Sigma 
Chemical Co., St. Louis,  Mo.) for 3 days. The cultures were pulsed with 0.5 ~Ci of [3H]TdR for 
the final 18 h of incubation before harvesting by the multiple sample harvester onto glass fiber 
filters for liquid scintillation  counting (17). 
For the fractionation of the mononuclear cells into T or non-T-cell subpopulations (18), the 
cells were resuspended in medium at 0.83 x  10e/ml final concentration containing 10 mM Hepes 
buffer and 32% fetal calf serum with a 50:1 ratio of sheep erythrocytes (SRBC) per lymphocyte 
and incubated at room  temperature overnight in a  5%  CO~ atmosphere to form spontaneous 
SRBC rosettes.  Cell  pellets  were  gently resuspended,  samples  removed for  enumeration of 
rosettes,  and the remainder gently underlaid with F-H and centrifuged. The pellet and the 
interface were collected  separately, and beth were treated with 0.83% Tris-NH4Cl  to lyse the 
remaining SRBC. The unfractionated cells were treated in a similar fashion with the omission of 
SRBC in the medium. The fraction that remained at the interface after centrifugation over F-H 
was designated non°T (T-depleted),  and the fraction that pelleted was designated T cells  (T- 
enriched). 
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TABLE  I 
Ability to Stimulate and Respond in One-Way MLC and Responsiveness  to Mitogens of 
Blood Leukocytes  from Patient C I-I. 
aH-cpm at day 3 for mitogens and day 6 for MLC stimulated by 
Responder lympho- 
cytes  Patient  Normal  Normal  Normal  Normal  Mitogens 
C.H.  C.D.  P.K  T.D.  S.C.  PHA  Con A 
Patient C.H.  386  9,330  9,591  15,482  18,892  17,159  6,091 
Normal C.D.  2,394  885  25,470  42,391  38,224  101,574  42,104 
Normal P.K.  18,021  15,928  573  32,756  35,126  88,505  31,615 
Normal T.D.  26,319  30,418  23,373  1,031  42,752  78,701  26,827 
Normal S.C.  36,377  23,009  31,807  45,102  1,885  67,238  30,330 
The numbers given are the arithmetic mean of three replicates of 125,000 responder and 125,000 irradiated stimulator cells or 
mitogens  for each test combination. The standard deviations (data not shown) for all combinations  shown in the Table averaged 12~. 
Results 
In our studies of the immune function of cancer patients  (17), the pattern of 
response  illustrated  in  Table  I  has  been  not  infrequently  observed.  Bladder 
cancer patient C.H. had a  decreased response to both mitogens and allogeneic 
cells when compared to the level of response of normal individuals.  In addition, 
his  leukocytes stimulated  normal  donor  C.D.  only weakly while  adequately 
stimulating  three  other  normal  donors,  which  is  generally  interpreted  as  a 
one-way MLC  (19) typing match.  However, in these experiments,  the dose of 
stimulator cells was also titrated.  Unexpectedly, leukocytes from patient C.H. 
produced a  reciprocal pattern of stimulation distinct from that usually seen in 
MLC, i.e., as the number of stimulator cells was increased, the weak response 
of normal C.D.  decreased (Table II). Yet, on the same day, when the patient's 
cells  were  used  to  stimulate  lymphocytes of other  normal  individuals,  they 
induced  perfectly normal  dose-response patterns  (cf.  normal  stimulator  cells 
S.D.  and B.D. Table II). Since patient C.H. stimulated lymphocytes from some 
normal  individuals  well  and  yet  apparently  suppressed  other  normals,  we 
suspected that his leukocytes might contain both competent stimulator cells as 
well as a population of suppressor cells which were acting in a restricted fashion. 
To  test this hypothesis, the patient's leukocytes were depleted of T  cells by removing SRBC 
rosetting cells (18) to determine whether the T.depleted lymphoid cells would stimulate lympho- 
cytes from a  normal individual who did not respond to the unfractionated cells (Table III). The 
unfractionated cells  and the T-enriched cells  failed to stimulate significant blastogenesis in the 
suppressible  i normal responder lymphocytes, but rather exhibited the reciprocal dose-response 
pattern, i.e.,  decreasing stimulation with increasing numbers of  stimulating cells.  However, the 
patient's  T-depleted (non-T) cells  were as effective  in stimulating that suppressible normal donor 
as were comparable cells  from an unrelated normal individual. 
Since  the  patient's non-T-cell fraction was  capable  of stimulating  both 
suppressible and nonsuppressible responders, we next examined whether the 
patient's  T cells  were actively interfering  with the ability  of  lymphocytes from 
the suppressible normal to respond to allogeneic stimuli (Table IV). For this 
1 For clarity of presentation, normal donors whose leukocytes responded only weakly and with 
a  reciprocal dose-response pattern to this patient's stimulator leukocytes in one-way MLC were 
designated as suppressible normals, whereas those normal donors responding to his stimulator 
cells in a  normal fashion are designated nonsuppressible. BEAN  ET  AL.  BRIEF  DEFINITIVE  REPORT  1457 
TABLE II 
Pattern of Decreasing MLC Responsiveness of a Suppressible Normal Donor When 
Incubated with Increasing Numbers of Irradiated Stimulator Cells from Patient C.H. 
3H-cpm at day 6 with stimulator cells from 
Number of  Responder lyre-  Number of  Stimu- 
phocytes  lator  lymphocytes  Normal  Normal  Normal  Patient 
C.D.  S.D.  B.D.  C.H. 
Normal C.D.  125,000  250,000  -  62,420  42,432  1,860 
125,000  554  46,038  24,556  5,874 
62,500  -  26,856  12,099  9,175 
Lymphocytes were prepared and used in MLC as described  in Materials and Methods. 
TABLE  HI 
MLC Response of a Suppressible Normal Donor to Subpopulations  of Lymphocytes 
from Patient C.H. and a Normal Donor 
SB-cpm at  day 6 of  MLC  stimulated by cells  from 
Number of  Normal J.C.  Patient C.H. 
Responder lymphocytes  stimulator 
lymphocytes  Unfrac-  Unfrac- 
T  Non-T  T  Non-T 
tionated  tionated 
Normal L.L.  125,000  125,000  45,872  28,586  50,116  866  778  48,208 
62,500  42,189  27,545  37,828  2,313  3,393  36,174 
Normal × normal  z = 546 cpm.  Percent E rosettes ior C.H.,  46°h; J.C., 62%. 
TABLE IV 
Ability ofT Cells from Patient C.H. to Suppress  the MLC Response of 
Lymphocytes  of Some Normals  but Not Others 
Non-T stimulater lym- 
Responder lymphocytes  phocytes 
3H-cpm at 6 days of  incubation 
with 62,500  non-T stimulater 
cells  and 
125,000  Patient 
Nothing  C.H. T lym- 
phocytes 
Suppressible  Normal L.L.  6,034  810 
normal L.L. 125,000  Normal P.K.  32,249  1,215 
Normal R.F.  29,996  1,257 
Normal J.G.  44,144  3,410 
Patient C.H.  20,886  1,573 
Nonsuppressible  Normal L.L.  24,502  24,876 
normal P,K.  125,000  Normal P.K.  2,572  21,797 
Normal R.F.  13,481  31,883 
Normal J.G.  37,962  51,800 
Patient C.H.  15,219  31,777 
Unfractionated responder lymphocytes were incubated with irradiated  non-T stimulator lymphocytes 
with or without 125,000  irradiated  patient  T lymphocytes as modulator cells. 
experiment,  unfractionated lymphocytes  from a  suppressible  and from a  non- 
suppressible individual were used as responding cells.  These cells were stimu- 
lated  by  the  irradiated  non-T-cell  fraction  from  several  allogeneic  normal 
individuals  in one-way  MLC  with  or without the  patient's  irradiated  T  cells 
added as modulator cells.  Clearly,  the patient's cells abrogated the responsive- 
ness  of the  suppressible  normal to this battery  of allogeneic  stimulator cells, 
but  did  not  interfere  with  the  response  of nonsuppressible  normal  donors. 
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also  depressed  the  response  of the  same  suppressible  normals  to  mitogenic 
stimulation. 
Blood leukocytes from this particular  patient have been used as stimulator 
cells  in  the  experimental  protocol shown in  Table I  with leukocytes from 27 
different unselected normal individuals as responder cells. Deficient stimulation 
of these  normal  leukocytes by the  patient's  stimulator  cells  similar  to  that 
shown  in  Table  I  was  seen  in  only  three  cases.  In  11  of these  27  normal 
combinations,  the  patient's  leukocytes  as  stimulator  cells  were  titrated  to 
determine  the  dose-response  curve.  Only  in  MLC  with  those  same  three 
normals  did  his  stimulator  cells  produce the  reciprocal  pattern  of a  further 
reduction in stimulation with increasing  numbers of stimulator cells identical 
to that shown in Table II. In 12 experiments similar to that shown in Table IV 
we used the patient's irradiated cells as modulator cells in one-way MLC with 
normal  donor lymphocytes as responder cells.  In each of the  12 experiments, 
his cells suppressed only the reactivity of leukocytes obtained from those three 
normals.  In  five  of these  experiments,  enrichment  of E-rosetting  cells  was 
performed and these cells were suppressive, whereas the T-depleted cells were 
not. 
In an attempt to clarify whether this restriction in suppressor activity was 
under  genetic control,  as reported in the  animal  models,  HLA typing of the 
patient  and  the  three  suppressible  normals  was  performed.  The  serological 
typing data are at present inconclusive as the patient did not type for the HLA- 
B locus  2 and reagents for human Ia typing were not available. 
As  another  approach  to  establishing  whether  this  T-cell  suppression  was 
genetically restricted, we reasoned that if there were a  genetic restriction,  the 
lymphocytes of one or both parents of each of the suppressible normals should 
be suppressed by the patient's lymphocytes. We were able to test the natural 
parents  of two of the  suppressible  normal  donors  in  an  experimental  design 
similar to that shown in Table IV. Unfractionated lymphocytes from both the 
mother  and father  of each of those two donors were stimulated  with several 
different  allogeneic  leukocytes to  induce  a  MLC  response.  The  patient's  and 
unrelated normal donor's irradiated  leukocytes were then added as modulator 
cells.  The  results  showed  that  only  one  parent  of each  of the  suppressible 
normals  was suppressed by the  patient's  leukocytes. Thus,  there  appeared to 
be a  probable genetic restriction to the expression of this suppressor activity, 
although  at present the gene or linkage  group with which the suppression is 
associated remains to be established. 
Discussion 
The  present  results  suggest  that  genetic  restriction  on  T-cell  suppression 
may  exist  in  humans  as  well  as  in  mice.  At  present,  it  is  not  possible to 
estimate  the  frequency of this  phenomenon  in cancer patient  populations  or 
speculate whether  it  is disease-related.  The  data reported here  are  from the 
study of a  male  patient  who had  not had transfusions  or chemotherapy and 
who continues to have  recurrent  bladder carcinomas.  We have  subsequently 
found  a  second  patient  who  has  allergic  asthma  who  exhibits  this  type  of 
2 Typing for HLA-A and HLA-B courtesy of the Fred Hutchinson Cancer Research Center. BEAN  ET  AL.  BRIEF  DEFINITIVE  REPORT  1459 
restricted  suppressor  activity  intermittently. Addition of his  leukocytes  as 
third party cells to MLC reactions depressed the ability of leukocytes from one 
normal  donor but  not  others  to  respond  to  unrelated  allogeneic  stimulator 
cells. When his leukocytes were used as stimulator cells in MLC, they produced 
the reciprocal pattern of stimulation against that one normal donor but not 
others. 
This finding of a genetically-restricted T-suppressor activity in man supports 
the generality of similar recent findings in  animal models  (12, 13,  16). The 
present  experiments  also  emphasize  the  difficulties in  detecting suppressor 
cells in man when the  activity may be restricted and,  thus,  detectable only 
with  normal  indicator  (responder)  leukocytes  from  a  small  percentage  of 
randomly selected individuals, except in the rare event that the subject being 
tested for suppressor cells has an identical twin or both parents living, healthy, 
and geographically available. Obviously, more studies are required to establish 
whether  this  apparently  genetically-restricted suppression  is  linked  to  the 
HLA complex and related to the incidence and course of disease. 
Summary 
Blood  leukocytes  from  an  immunologically hyporesponsive  patient  with 
urinary  bladder  carcinoma  were  found  to  be  deficient  in  their  ability  to 
stimulate 3 of 27 responder leukocyte preparations from normal individuals in 
one-way mixed leukocyte culture (MLC). The patient's T-depleted leukocytes, 
however,  functioned adequately as  stimulator cells.  T-enriched  lymphocytes 
from this patient suppressed the MLC responsiveness of those three normals 
but not the responsiveness of other normals. The patient's cells suppressed the 
MLC responsiveness of only one of each of the parents of two of the normals 
who  could  be  suppressed  by  the  patient's  leukocytes suggesting  a  possible 
genetic restriction to this suppressor cell activity. 
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